Human siGENOME RTF - Apoptosis

The only ready-to-use siRNA screening libraries available

A ready-to-use Reverse Transfection format (RTF) RNAi screening library targeting human apoptosis genes. Just resuspend pre-dispensed siRNA, and add cells. Optimization plates available.

The Human siGENOME RTF Apoptosis SMARTpool siRNA Library includes SMARTpool siRNA reagents targeting apoptosis-related genes, allowing for comprehensive analysis of the entire apoptotic pathway. Targets include both cytoplasmic and membrane-bound proteins implicated in programmed cell death, including caspase, Bcl-2, and tumor necrosis factor (TNF) families.

RTF siRNA libraries are provided as multiple single-use plate sets – just rehydrate, and add cells. This unique pre-plated format reduces hands-on time for faster screening results.

siGENOME siRNAs are designed with the proprietary SMARTselection design algorithm for high-efficiency, guaranteed silencing. They also incorporate rational strand bias with application of ON-TARGET modifications to optimize antisense strand loading into RISC for effective target knockdown.


  • Six ready-to-use 96-well plate sets provided for two triplicate screens
  • Pre-plated, validated RNAi controls included
  • No aliquoting necessary, just resuspend and add cells
  • siRNA reagents provided in clear plates at 6.25 pmol per well (50 nM final screening concentration)
  • Black or white clear-bottom plates available to support assays involving fluorescent or luminescent detection
For a diagram of the RTF Library Plate layout, see Figure 1 on the Supporting data tab.
Well Pre-plated control Control Catalog No.
A1 siGENOME Non-targeting siRNA #2 D-001210-02
B1 siGENOME Non-targeting siRNA #3 D-001210-03
C1 siGENOME Non-targeting siRNA #4 D-001210-04
D1 siGENOME Non-targeting siRNA #5 D-001210-05
E1 siGENOME Non-targeting pool #2 D-001206-14
F1 siGENOME Cyclophilin B control pool (H, M, R) Control siRNA D-001136-01

Experimental considerations

DharmaFECT Cell Culture Reagent (DCCR) is recommended for use with RTF libraries to dilute transfection reagents prior to use. DCCR may be purchased separately or accompanying your RTF Optimization Plates

DharmaFECT transfection reagents are highly recommended for use with RTF libraries and should be purchased separately. Refer to the DharmaFECT Cell Type Guide to find the appropriate formulation for your cell type.

Shipping ConditionAmbient
Stability at Recommended Storage ConditionsAt least 12 months
Storage Condition4 C

Our siRNA knockdown guarantee

siGENOME and ON-TARGETplus siRNA reagents (SMARTpool and three of four individual siRNAs) are guaranteed to silence target gene expression by at least 75% at the mRNA level when used under optimal delivery conditions (confirmed using validated positive control and measured at the mRNA level 24 to 48 hours after transfection using 100 nM siRNA).

Note: Most siGENOME and ON-TARGETplus siRNA products are highly functional at 5 to 25 nM working concentration.

siGENOME RTF Plate Layout

Plate layout of siGENOME RTF siRNA Libraries

siGENOME RTF Plate Layout

Figure 1. | Validated control siRNAs and pools are pre-dispensed into column 1 of each RTF Library plate, providing a consistent baseline for screening and assay efficiency.

RTF Protocol Overview

Simple four-step protocol for screening with RTF SMARTpool siRNA Libraries

RTF Protocol Overview

Figure 2. |

Reverse Transfection Format is highly effective across cell lines

Reverse Transfection Format is highly effective across cell lines

Reverse Transfection Format is highly effective across cell lines

Figure 3. | Reverse transfection Format was used to assess control gene silencing (Cyclophilin B; blue bars) and viability (yellow dots) across eight cell lines under optimized conditions. In all cases, effective target gene knockdown was achieved with low cytotoxicity.


  1. Publications using RTF Libraries

    T. Sorkina, M. Miranda, K.R. Dionne, B.R. Hoover, N.R. Zahniser, A. Sorkin, RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis. J Neurosci. 26(31), 8195-205 (2006).

  2. P. Monteiro, D. Gilot, E. Le Ferrec, C. Rauch, D. Lagadic-Gossmann, O. Fardel, Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway. Mol Pharmacol. 73(3), 769-77 (Epub 18 December 2007, March 2008).
  3. A. A. Kolokoltsov, D. Deniger, E. H. Fleming, N.J. Roberts Jr, J. M. Karpilow, R. A. Davey, Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol. 81(14), 7786-800 (Epub 9 May 2007, July 2007).
  4. K. M. Hussain, K. L. Leong, M. M. Ng, J. J. Chu, The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem. 286(1), 309-321 (Epub 18 October 2010, 7 January 2011).
  5. General Screening References

    B. D. Parsons, A. Schindler, D. H. Evans, E. Foley, A direct phenotypic comparison of siRNA pools and multiple individual duplexes in a functional assay. PLoS One. 4(12), e8471 (2009).

  6. M. Jiang, R. Instrell, B. Saunders, H. Berven, M. Howell, Tales from an academic RNAi screening facility; FAQs. Brief Funct. Genomics. 10(4), 227-237 (2011). [doi: 10.1093/bfgp/elr016]